Prostate cancer metastatic – Life with Disease

Go back

Metastatic prostate cancer is a condition where cancer that began in the prostate has spread to other parts of the body, most commonly to the bones, lymph nodes, lungs, or liver. While this stage cannot be cured, treatments can help control the cancer, reduce symptoms, and extend life for many years.

Prognosis and Life Expectancy

Understanding what to expect when diagnosed with metastatic prostate cancer can feel overwhelming, but it’s important to remember that every person’s journey is unique. The outlook depends on many factors including where the cancer has spread, how aggressive it is, your overall health, and how well your body responds to treatment.[1]

While metastatic prostate cancer cannot be cured, medical advances in recent years have significantly improved survival times. Historical data from more than 50 years ago showed that patients with bone metastases at diagnosis had a median survival of 30 to 36 months. However, modern treatments have extended these timelines considerably.[6] Recent studies indicate that median overall survival has improved to approximately 42 months, with two-year survival rates reaching 72%. This improvement reflects the introduction of new combination therapies and more effective medications.[6]

Many men with advanced prostate cancer are able to live normal lives for a number of years. Treatment can help control the disease for months or even years, allowing patients to maintain their quality of life and continue activities that matter to them.[2] The goal of treatment is not only to extend life but also to help patients feel as well as possible during that time.[17]

It’s worth noting that not all patients who have cancer cells in their bones will develop full-blown bone metastases. The presence of disseminating tumor cells does not always lead to active metastatic disease, as the fate of these cells is greatly influenced by the surrounding environment in the body.[6]

⚠️ Important
Your doctor has the most complete picture of your individual situation and is the best person to discuss your specific prognosis. Survival statistics are averages based on large groups of people and may not reflect your personal experience. Your specialist nurse can also help you understand what these numbers mean for you personally.

Natural Progression Without Treatment

When prostate cancer spreads beyond the prostate gland without treatment, it follows patterns that can vary from person to person. The cancer typically travels through the bloodstream or lymphatic system—the body’s network of vessels and organs that help fight infection—to reach distant parts of the body.[3]

The bones are the most common destination for metastatic prostate cancer, followed by lymph nodes in areas away from the prostate, and then organs such as the lungs and liver.[2] When cancer cells settle in the bones, they can cause structural changes that lead to pain, weakness, and increased risk of fractures. Without intervention, these bone changes can become increasingly problematic over time.

Prostate cancer relies heavily on testosterone—a male hormone—to fuel its growth. In its natural course without treatment, the cancer continues to receive this hormonal fuel and can grow progressively. As the disease advances, symptoms tend to worsen. Patients may experience increasing fatigue, unintentional weight loss, and more frequent urinary problems.[1]

The rate at which metastatic prostate cancer progresses varies widely. Several factors influence how aggressively the cancer behaves, including its Gleason score or Grade Group—numbers that describe how abnormal the cancer cells look under a microscope—and the amount of tumor present in the body.[3] Some cancers progress slowly over years, while others advance more rapidly.

Eventually, without treatment, the growing cancer burden affects the body’s ability to function normally. The spread to vital organs can interfere with their normal operations, leading to serious complications. Understanding this natural progression helps explain why treatment, even when it cannot cure the disease, remains so valuable in controlling symptoms and maintaining quality of life.

Possible Complications

Metastatic prostate cancer can lead to various complications as the disease affects different parts of the body. Being aware of these potential problems helps patients and their healthcare teams respond quickly when they occur.

Bone complications are among the most common and serious issues. When cancer spreads to bones, it can weaken the bone structure, making fractures more likely even from minor injuries or sometimes without any injury at all. The bones most often affected include those in the spine, pelvis, ribs, and thighs.[3] Pain in these areas tends to worsen over time and can become severe, affecting sleep, mobility, and daily activities.[1]

A particularly urgent complication is metastatic spinal cord compression, which happens when cancer in the spine puts pressure on the spinal cord or the nerves coming from it. This is a medical emergency that requires immediate attention. Warning signs include new back pain, difficulty walking, numbness or weakness in the legs, or problems controlling the bladder or bowels.[20]

Urinary complications can develop as the primary tumor in the prostate grows larger, even after the cancer has spread elsewhere. The enlarged prostate can press against the urethra—the tube that carries urine out of the body—making urination difficult or painful. Some men experience a frequent, urgent need to urinate, particularly at night.[1]

Bowel problems may occur if the cancer affects areas near the rectum or if treatments impact digestive function. Changes in bowel habits, constipation, or discomfort during bowel movements can affect quality of life and require management strategies.[20]

Severe fatigue is another common complication that goes beyond normal tiredness. This profound exhaustion doesn’t improve with rest and can make it difficult to perform everyday activities. The fatigue may result from the cancer itself, the body’s response to it, or as a side effect of treatments.[1]

Some patients experience unintended weight loss, which can occur even when eating normally. This happens because cancer can change the way the body processes nutrients and uses energy.[1] Nausea and vomiting may also develop, affecting appetite and making it harder to maintain proper nutrition.

When cancer spreads to organs like the lungs or liver, it can affect how those organs work. Lung metastases might cause shortness of breath or persistent cough, while liver involvement could lead to abdominal discomfort or changes in liver function.

Impact on Daily Life

Living with metastatic prostate cancer affects many aspects of everyday life, from physical abilities to emotional well-being and relationships. Understanding these impacts can help patients and families prepare and find ways to cope.

Physically, the disease and its treatments can bring significant changes. Bone pain may limit mobility and make activities like walking, climbing stairs, or carrying objects more difficult. Some men find they need to adjust how they move through their day, perhaps using assistive devices or asking for help with tasks they previously managed alone.[20] Fatigue can be particularly challenging because it affects energy levels unpredictably—patients may feel reasonably well one day and exhausted the next.[20]

Work life often requires adjustments. Some men continue working throughout treatment, while others need to reduce hours or take extended leave. The unpredictability of symptoms and treatment schedules can make planning difficult. Employers may need to provide flexibility for medical appointments and accommodate periods when energy is low.

Sexual health and intimate relationships frequently change when dealing with metastatic prostate cancer. Hormone therapy, which is a cornerstone of treatment, works by lowering testosterone levels. This can reduce sexual desire and affect the ability to have erections. These changes can feel distressing and affect self-image and relationships.[20] Open communication with partners becomes essential, as does discussing these concerns with healthcare providers who can suggest ways to adapt.

Social activities and hobbies may need modification but don’t have to stop entirely. Many patients find creative ways to continue enjoying activities they love, perhaps in different forms or at a different pace. Planning activities for times when energy is typically better can help maximize participation. It’s also perfectly acceptable to decline invitations when not feeling well, and true friends will understand.

The emotional impact of metastatic prostate cancer is significant and completely normal. Learning that your cancer cannot be cured is distressing and can trigger a range of feelings including shock, anxiety, fear, sadness, and anger.[2] It’s common to feel uncertain about the future and to have trouble thinking about anything else, especially in the period right after diagnosis.[17]

Many men find it helpful to learn as much as they can about their condition and treatment options. Having information can restore a sense of control and make decision-making easier. However, some people prefer to focus on one day at a time rather than looking too far ahead—both approaches are valid.[17]

Practical matters also require attention. Financial concerns may arise from medical costs, loss of income, or the need to modify living spaces for accessibility. Planning for the future, including discussing priorities and wishes with family members, can feel difficult but often brings peace of mind.[17]

Coping strategies vary by individual, but many patients find support through counseling, support groups where they can connect with others facing similar challenges, or talking with specialist nurses who understand the disease intimately. Physical activity, when possible, often helps both physically and emotionally. Even gentle exercises like short walks can improve mood and energy levels.[20]

It’s important to communicate openly with your healthcare team about all symptoms and concerns—not just physical pain but also emotional distress, relationship difficulties, or practical worries. They can connect you with resources and specialists who can help with different aspects of living with advanced cancer.[17]

⚠️ Important
Feeling as well as possible is crucial. Always tell your doctor or specialist nurse about any symptoms you’re experiencing, whether physical or emotional. They can help control symptoms and connect you with support services. You don’t have to cope with everything on your own—help is available.

Support for Families and Clinical Trial Information

Family members and loved ones play a vital role when someone is living with metastatic prostate cancer, including during participation in clinical trials. Understanding how to provide support while also taking care of themselves is essential for everyone involved.

Clinical trials are research studies that test new treatments or new ways of using existing treatments. For patients with metastatic prostate cancer, clinical trials can provide access to cutting-edge therapies that aren’t yet widely available. These studies are crucial for developing better treatments and ultimately finding a cure.[2]

When considering clinical trials, families should understand what they involve. The patient may be asked to take experimental medications, undergo additional testing, or follow specific treatment schedules. It’s essential that patients and families discuss the potential benefits and risks with their healthcare team. No one should feel pressured to join a trial—it’s a personal decision that should be made with full information.[4]

Families can help by attending appointments where clinical trials are discussed, taking notes, and asking questions. It’s easy for patients to feel overwhelmed during these conversations, so having another person present to listen and remember details is valuable. Questions families might help ask include: What is the purpose of this trial? What are the potential benefits and risks? How will it affect daily life? What happens if the treatment doesn’t work or causes problems?

If a loved one decides to participate in a clinical trial, families can support them by helping track appointments and medication schedules, watching for side effects, and communicating with the healthcare team about any concerns. Many trials require frequent visits or additional tests, which may need transportation assistance or companionship.

Beyond clinical trials, families support their loved ones in many other ways. Simply being present and willing to listen is often the most valuable gift. Some people want to talk extensively about their diagnosis and feelings, while others prefer not to dwell on it. Following the patient’s lead regarding how much they want to discuss their condition respects their autonomy and coping style.[17]

Practical help is often appreciated. This might include assistance with transportation to appointments, help with household tasks, meal preparation, or managing medications. However, it’s important to ask what help is wanted rather than assuming or taking over—many patients value maintaining independence and control over their lives as much as possible.

Family members should also be aware of their own emotional needs. Watching someone you love deal with cancer is stressful and can trigger feelings of helplessness, fear, sadness, or anger. These feelings are normal and deserve attention. Many cancer centers offer support specifically for family members and caregivers, including counseling services and caregiver support groups.[17]

Communication within families can become strained during this time. Some family members may want to discuss the illness openly while others avoid the topic, or disagreements may arise about treatment decisions. It can help to designate one family member as the primary contact with medical teams to avoid confusion, while ensuring information is shared appropriately with everyone who needs or wants to know.

Planning ahead together, when the patient is ready to do so, can reduce anxiety about the future. This might include discussing treatment preferences, financial arrangements, or simply what matters most to the patient in terms of how they spend their time. These conversations can be difficult but often strengthen relationships and provide peace of mind for everyone involved.[17]

Specialist nurses and social workers at cancer centers are excellent resources for families. They can provide information about the disease and treatments, offer emotional support, help navigate practical challenges like financial assistance programs, and connect families with community resources. Don’t hesitate to reach out to them—they’re there to help the whole family, not just the patient.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Goserelin – A hormone therapy drug that suppresses testosterone production, used as a first-line treatment for metastatic prostate cancer
  • Leuprolide – Another form of androgen deprivation therapy that reduces testosterone levels in the body
  • Degarelix – A hormone therapy option that blocks testosterone, offered as an alternative to goserelin
  • Apalutamide – An androgen receptor signaling inhibitor used in combination with other hormone therapies
  • Enzalutamide – Another androgen receptor signaling inhibitor that can be combined with hormone therapy
  • Darolutamide (Nubeqa) – Used in combination with docetaxel and prednisone along with hormone therapy
  • Docetaxel – A chemotherapy drug used in combination therapy for metastatic hormone-sensitive prostate cancer
  • Prednisone – A corticosteroid used in combination with other treatments
  • Dexamethasone – Another corticosteroid option for treatment
  • Zoledronic acid (Zometa) – A bisphosphonate used to treat bone metastases
  • Denosumab (Xgeva) – A monoclonal antibody therapy for bone metastases
  • Radium-223 dichloride (Xofigo) – A systemic radiation therapy specifically for bone metastases
  • Olaparib – A targeted therapy (PARP inhibitor) for patients with certain genetic characteristics
  • Sipuleucel-T – An immunotherapy treatment for metastatic castration-resistant prostate cancer
  • Lutetium-177 vipivotide tetraxetan (Pluvicto) – A radioligand therapy that targets PSMA on prostate cancer cells

Ongoing Clinical Trials on Prostate cancer metastatic

  • Study on the Effectiveness of Abiraterone, Capivasertib, and Enzalutamide in Patients with Metastatic Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Norway Sweden
  • Study on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer

    Recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Greece +5
  • Study of Gedatolisib and Darolutamide Combination Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    France Spain
  • Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Ireland Italy The Netherlands +4
  • A study to evaluate the safety and effectiveness of AZD9750 and saruparib in patients with metastatic prostate cancer

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands Spain
  • Comparing Copper (64Cu) Chloride PET/CT and Fluorocholine (18F) PET/CT for Detecting Metastasis in Prostate Cancer Patients at Risk

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Italy
  • Study on Using Copper (64Cu) Chloride PET/CT Imaging for Prostate Cancer Patients with Biochemical Relapse After Surgery to Guide Radiation Therapy

    Not yet recruiting

    3 1 1
    Investigated drugs:
    Italy
  • Study of Fuzuloparib, Abiraterone Acetate, and Prednisone for First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Belgium Czechia France Hungary Poland Spain
  • Study of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Czechia France Germany Greece Hungary Italy +5
  • Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium Czechia France Greece Hungary The Netherlands +2

References

https://www.mayoclinic.org/diseases-conditions/metastatic-prostate-cancer/symptoms-causes/syc-20377966

https://www.cancerresearchuk.org/about-cancer/prostate-cancer/metastatic-cancer/what-is-metastatic-prostate-cancer

https://zerocancer.org/stages-and-grades/metastatic-prostate-cancer

https://www.mdanderson.org/cancerwise/what-to-know-about-metastatic-prostate-cancer.h00-159703068.html

https://www.pcf.org/patient-support/diagnosis/metastatic-prostate-cancer/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6396340/

https://emedicine.medscape.com/article/454114-overview

https://www.mayoclinic.org/diseases-conditions/metastatic-prostate-cancer/diagnosis-treatment/drc-20377972

https://www.mskcc.org/cancer-care/types/prostate/treatment/metastatic-prostate-cancer-treatments

https://www.cancer.gov/news-events/cancer-currents-blog/2025/metastatic-prostate-cancer-combination-treatments

https://pmc.ncbi.nlm.nih.gov/articles/PMC9856730/

https://www.mdanderson.org/cancerwise/what-to-know-about-metastatic-prostate-cancer.h00-159703068.html

https://zerocancer.org/treatment-options/metastatic-treatments

https://cancer.ca/en/cancer-information/cancer-types/prostate/treatment/metastatic-castration-sensitive

https://www.uchicagomedicine.org/cancer/types-treatments/prostate-cancer/treatment/metastatic-prostate-cancer

https://www.cancerresearchuk.org/about-cancer/prostate-cancer/metastatic-cancer/treatment/options

https://www.cancerresearchuk.org/about-cancer/prostate-cancer/metastatic-cancer/coping

https://www.mdanderson.org/cancerwise/what-to-know-about-metastatic-prostate-cancer.h00-159703068.html

https://www.mayoclinic.org/diseases-conditions/metastatic-prostate-cancer/diagnosis-treatment/drc-20377972

https://prostatecanceruk.org/prostate-information-and-support/advanced-prostate-cancer/managing-symptoms-in-advanced-prostate-cancer

https://zerocancer.org/stages-and-grades/metastatic-prostate-cancer

https://www.fredhutch.org/en/news/center-news/2024/01/22-years-with-metastatic-prostate-cancer.html

https://www.cancer.gov/news-events/cancer-currents-blog/2025/metastatic-prostate-cancer-combination-treatments

https://www.cancer.org/cancer/types/prostate-cancer/after-treatment.html

FAQ

Can metastatic prostate cancer be cured?

Unfortunately, metastatic prostate cancer cannot be cured. When cancer has spread beyond the prostate to distant parts of the body such as bones, lymph nodes, or organs, it is no longer possible to eliminate all cancer cells. However, many treatments are available that can control the disease for years, reduce symptoms, and help patients maintain a good quality of life. Many men with metastatic prostate cancer live for years with their condition.

Where does prostate cancer most commonly spread?

Prostate cancer most frequently spreads to the bones, particularly the spine, pelvis, ribs, and thighs. After bones, it commonly spreads to lymph nodes in areas away from the prostate, followed by the lungs and liver. Less commonly, it can spread to the brain. The cancer cells travel through the bloodstream or lymphatic system to reach these distant sites.

What is the life expectancy for someone with metastatic prostate cancer?

Life expectancy varies greatly depending on individual factors including where the cancer has spread, how aggressive it is, overall health, and response to treatment. Recent data shows that median overall survival has improved to approximately 42 months, with two-year survival rates of about 72%. However, many men live much longer than these averages, and some live for many years with their disease controlled by treatment. Your doctor can provide more personalized information based on your specific situation.

What are the main symptoms of metastatic prostate cancer?

Many people with metastatic prostate cancer don’t have symptoms initially. As the cancer advances, symptoms may include bone pain that worsens over time (especially in the back, hips, or pelvis), extreme fatigue, more frequent or painful urination, unintentional weight loss, and nausea. Symptoms depend partly on where the cancer has spread. It’s important to report any new or worsening symptoms to your healthcare team.

What is the standard first treatment for metastatic prostate cancer?

Current guidelines recommend starting with combination therapy rather than a single drug. This typically includes androgen deprivation therapy (such as goserelin or leuprolide) combined with an androgen receptor signaling inhibitor (such as apalutamide or enzalutamide). For high-risk patients, adding chemotherapy with docetaxel may be recommended, creating what’s called triplet therapy. This intensified approach has been shown to help people live longer and maintain better quality of life compared to hormone therapy alone.

🎯 Key takeaways

  • Metastatic prostate cancer cannot be cured, but modern treatments can control it for years and significantly improve quality of life
  • Survival times have dramatically improved—median survival is now around 42 months, but many men live much longer
  • Combination treatments work better than single drugs, yet many doctors still aren’t prescribing them despite clear evidence
  • Bone metastases are the most common complication and can cause pain, fractures, and spinal cord compression requiring urgent attention
  • Contrary to concerns, patients on combination therapy actually report better quality of life because their symptoms improve faster
  • Living with metastatic prostate cancer affects physical abilities, relationships, work, and emotional well-being—all of which deserve attention and support
  • Clinical trials offer access to promising new treatments and families can help by attending appointments, asking questions, and tracking information
  • Not all disseminating cancer cells in bones develop into full metastases—the body’s microenvironment influences whether they grow